PP
NWBO

PDT Partners’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

PDT Partners’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-50,486
Closed -$366K – 1874
2014
Q1 		$366K Buy
+50,486
New +$299K 0.01% 1069

Other funds holding NWBO

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PDT Partners's NWBO Position: Q2 2014 in Review

PDT Partners sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q2 2014, closing a stake of 50,486 shares — an estimated $366K sold.

PDT Partners first reported a position in NWBO in Q1 2014 and held it in 1 quarter. The position peaked at $366K in Q1 2014. 80 funds tracked by Wall St. Rank hold NWBO as of Q2 2014.

  • PDT Partners reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q2 2014 after selling out during the quarter.
  • PDT Partners sold 50,486 Northwest Biotherapeutics, Inc. Common stock shares in Q2 2014, an estimated $366K.
  • PDT Partners first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q1 2014 and held it in 1 quarter.
  • PDT Partners's Northwest Biotherapeutics, Inc. Common stock position peaked at $366K in Q1 2014.
  • 80 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q2 2014.

Based on PDT Partners's 13F filing for Q2 2014, filed 14 Aug 2014.